MannKind Corporation Reports 2024 First Quarter Financial Results: Provides Clinical Development Update
May 08, 2024 16:18 ET
|
MannKind
1Q 2024 Total revenues of $66M; +63% vs. 1Q 20231Q 2024 Net income of $11M; Non-GAAP net income of $15M$304M of cash and cash equivalents and investments at March 31, 2024In early April, repaid Midcap...
StoneX Group Inc. Reports Fiscal 2024 Second Quarter Financial Results
May 08, 2024 16:17 ET
|
StoneX Group Inc.
Quarterly Operating Revenues of $818.2 million, up 16% Quarterly Net Income of $53.1 million, ROE of 14.0% Quarterly Diluted EPS of $1.63 per share, up 25% NEW YORK, May 08, 2024 (GLOBE...
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
May 08, 2024 16:16 ET
|
Catalyst Pharmaceuticals, Inc.
Achieved Total Q1 2024 Revenues of $98.5 Million, a 15.4% YoY Increase, Underscored by Exceptional Execution and Continued Demand for Commercial Products FIRDAPSE® Q1 2024 Net Product Revenues of...
Paycor Announces Third Quarter Fiscal Year 2024 Financial Results
May 08, 2024 16:15 ET
|
Paycor HCM, Inc.
Q3 Total revenues of $187.0 million, an increase of 16% year-over-year, while expanding operating margins Q3 Recurring revenue of $172.0 million, an increase of 14% year-over-year FY’24 revenue...
Fossil Group, Inc. Reports First Quarter 2024 Financial Results
May 08, 2024 16:15 ET
|
Fossil Group, Inc.
Maintains Full Year 2024 Outlook RICHARDSON, Texas, May 08, 2024 (GLOBE NEWSWIRE) -- Fossil Group, Inc. (NASDAQ: FOSL) today announced financial results for the first quarter ended March 30, 2024. ...
Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
May 08, 2024 16:15 ET
|
Merus N.V.
Petosemtamab in combination with pembrolizumab in 1L HNSCC initial interim clinical data at 2024 ASCO Annual Meeting; preparing for a potential phase 3 trialZeno BLA accepted for priority review by...
The Honest Company Reports First Quarter 2024 Results
May 08, 2024 16:15 ET
|
The Honest Company, Inc.
Transformation Pillars Continue to Drive Revenue Growth and Profitability ImprovementAchieved 37% Gross Margin, Significant Expansion of 1,275 Basis Points Year-Over-YearReaffirms Full Year 2024...
Precision Optics Corporation Schedules Third Quarter of Fiscal Year 2024 Conference Call for Wednesday, May 15, 2024
May 08, 2024 16:15 ET
|
Precision Optics Corporation
GARDNER, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the...
Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference
May 08, 2024 16:15 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., May 08, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the...
Dentsply Sirona to Participate in Upcoming Investor Conferences
May 08, 2024 16:15 ET
|
DENTSPLY SIRONA Inc.
CHARLOTTE, N.C., May 08, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences. Bank of America...